Funding competition Sustainable Medicines Manufacturing: Expression of interest

Innovate UK, part of UK Research and Innovation, will work with the Department of Health and Social Care (DHSC) to invest up to £1 million in expression of interest (EoI) projects for Grand Challenges in sustainable medicines manufacturing.

Competition opens: Wednesday 14 August 2024
Competition closes: Wednesday 16 October 2024 11:00am

Start new application

Or sign in to continue an existing application.

Description

The aim of this competition is to provide seed funding to establish a consortium and prepare a case for a later, full sustainable medicine manufacturing themed Grand Challenge award. A Grand Challenge is a large-scale collaborative research and development (CR&D) award, up to £10 million, involving at least three partners across the medicines manufacturing supply chain.

We define sustainable medicines manufacturing as the process of producing medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability. This approach focuses on reducing waste, energy consumption and emissions, while enhancing efficiency, safety and cost-effectiveness throughout the manufacturing lifecycle. It also includes the adoption of innovative technologies and practices that promote the long-term viability of the medicines manufacturing industry.

This competition will help unlock potential by giving organisations the capacity to collaborate in developing new innovations, technologies, tools, data sets and approaches that can ultimately contribute to a sustainable medicines manufacturing sector.

This is phase 1 of a 2-phase competition:

Phase 1: expressions of interest (EoI) phase (this competition)
Phase 2: full Grand Challenge phase

At this EoI phase we will support projects to:

build consortia
complete background information and data gathering
develop a proposal for the Grand Challenge phase

Only successful applicants at this EoI phase will be invited to apply for the Grand Challenge phase.

In applying to this competition, you are entering into a competitive process. This competition has a funding limit, so we may not be able to fund all the proposed projects. It may be the case that your project scores highly but we are still unable to fund it.

This competition closes at 11am UK time on the deadline stated in this Innovate UK competition brief. We cannot guarantee other government or third party sites will always show the correct competition information.

Funding type

Grant

Project size

Your project’s total costs and grant funding request for the EoI phase can be up to £100,000.

Accessibility and Inclusion

We welcome and encourage applications from people of all backgrounds and are committed to making our application process accessible to everyone. This includes making reasonable adjustments, for people who have a disability or a long-term condition and face barriers applying to us.

You can contact us at any time to ask for guidance.

We recommend you contact us at least 15 working days before this competition’s closing date to allow us to put the most suitable support in place. The support we can provide may be limited if you contact us close to the competition deadline.

You can contact Innovate UK by email or call 0300 321 4357. Our phone lines are open from 9am to 12pm and 2pm to 5pm UK time, Monday to Friday (excluding bank holidays).

Who can apply

Your project

Your project must:

have a grant funding request up to £100,000
last between three and six months
carry out its project work in the UK
intend to exploit the results from or in the UK
start by 1 January 2025
end by 30 June 2025

Projects must always start on the first of the month. You must not start your project until your Grant Offer Letter has been approved by Innovate UK. Any delays within Project Setup may mean we need to delay your project start date.

You must only include eligible project costs in your application.

You will be made ineligible if you exceed the Minimal Financial Assistance limit. Each business partner must complete an MFA declaration as part of their application.

Lead organisation

To lead a project or work alone your organisation must be a UK registered:

business of any size
research and technology organisation (RTO)
catapult centre
public sector organisation

More information on the different types of organisation can be found in our Funding rules.

Project team

To collaborate with the lead, your organisation must be a UK registered:

business of any size
academic institution
charity
not-for-profit
public sector organisation
research and technology organisation (RTO)
catapult centre

Each partner organisation must be invited into the Innovation Funding Service (IFS) by the lead to collaborate on a project. Once partners have accepted the invitation, they will be asked to login or to create an account in IFS. They are responsible for entering their own project costs in the application.

At the EoI phase you may apply as a single applicant or collaboration but you are not required to have a fully formed consortia. Full Grand Challenge projects will require at least three organisations from across the supply chain (where appropriate) interested in forming a network. For collaborations, the organisations do not need to have worked together before and can develop their relationship during this EoI phase.

To be an eligible collaboration, the lead and at least one other organisation must apply for funding when entering their costs into the application.

Non-funded partners

Your project can include partners that do not receive any of this competition’s funding. Their costs will count towards the total eligible project costs.

Subcontractors

Subcontractors are not allowed for the expression of interest (EoI) phase but will be considered for the Grand Challenge phase.

Number of applications

For the EoI phase, an eligible organisation can lead on more than one application and can be included as a collaborator in any number of applications.

For the EoI phase if a business of any size, academic institution, charity, not-for-profit, public sector organisation, research and technology organisation (RTO) or catapult is not leading they can collaborate on any number of applications.

Sanctions

This competition will not fund you, or provide any financial benefit to any individual or entities directly or indirectly involved with you, which would expose Innovate UK or any direct or indirect beneficiary of funding from Innovate UK to UK Sanctions. For example, through any procurement, commercial, business development or supply chain activity with any entity as lead, partner or subcontractor related to these countries, administrations and terrorist groups.

Use of animals in research and innovation

Innovate UK expects and supports the provision and safeguarding of welfare standards for animals used in research and innovation, according to best practice and up to date guidance.

Applicants must ensure that all of the proposed work within projects, both that in the UK and internationally, will comply with the UKRI guidance on the use of animals in research and innovation.

Any projects selected for funding which involve animals will be asked to provide additional information on welfare and ethical considerations, as well as compliance with any relevant legislation as part of the project start-up process. This information will be reviewed before an award is made.

Previous applications

You cannot use a previously submitted application to apply for this competition.

We will not award you funding if you have:

failed to exploit a previously funded project
an overdue independent accountant’s report
failed to comply with grant or award terms and conditions

Minimal Financial Assistance (and De minimis where applicable)

Grant funding in this competition is awarded as Minimal Financial assistance (MFA). This allows public bodies to award up to £315,000 to an enterprise in a 3-year rolling financial period.

In your application, you will be asked to declare previous funding received by you. This will form part of the financial checks ahead of Innovate UK making a formal grant offer.

To establish your eligibility, we need to check that our support added to the amount you have previously received does not exceed the limit of £315,000 in the ‘applicable period’.

The applicable period is made up of:

(a) the elapsed part of the current financial year, and

(b) the two financial years immediately preceding the current financial year.

You must include any funding which you have received during the applicable period under:

Minimal Financial Assistance (previously referred to as Special Drawing Rights)
De Minimis Regulation

You do not need to include aid or subsidies which have been granted on a different basis, for example, an aid award granted under the General Block Exemption Regulation.

Further information about the Subsidy Control Act 2022 requirements can be found in the Subsidy Control Act 2022 (legislation.gov.uk).

EU Commission rules now only apply in limited circumstances. Please see the Windsor Framework to check if these rules apply to your organisation.

Further information

If you are unsure about your obligations under the Subsidy Control Act 2022, you should take independent legal advice. We cannot advise on individual eligibility or your legal obligations.

Funding

We have allocated up to £1 million to fund projects in this EoI phase competition.

Your total project costs will be up to 100% funded. The total project costs and grant funding request detailed within your application must match and must not exceed the maximum project size of £100,000. If your total project costs or grant funding request exceed the maximum then your application will be made ineligible.

You can make reference to any additional voluntary contribution in your application answers. It must not be detailed in the finance section.

Within your collaboration, priority for funding should be given to the organisations that would not be able to participate in your proposal’s development without financial assistance.

For more information on company sizes, please refer to the Company accounts guidance.

If you are applying for an award funded under European Commission Regulations, the definitions are set out in the European Commission Recommendation of 6 May 2003.

Research participation

The research organisations undertaking non-economic activity as part of the project can share up to 100% of the total eligible project costs. If your consortium contains more than one research organisation undertaking non-economic activity, this maximum is shared between them. Of that 100% you can get funding for your eligible project costs of up to:

80% of full economic costs (FEC) if you are a Je-S registered institution such as an academic
100% of your eligible project costs if you are an RTO, charity, not for profit organisation, Catapult centre, public sector organisation or research organisation

Your proposal

In the Grand Challenge phase we aim to support organisations with the potential to innovate and develop technologies for sustainable medicines manufacturing. Your project must address at least one of these three key pillars:

green chemistry
circularity
productivity and resource efficiency

Your project must also address both critical enablers:

regulations
measurements, standards and data

Your Grand Challenge project must demonstrate measurable improvements which lead to more sustainable processes, in at least one of the following areas:

productivity
waste reduction
emissions reduction
energy use reduction
resource efficiency

Expression of interest phase (EoI)

Funding for this EoI phase must be used to support the collaborative development of your application for the Grand Challenge phase.

This includes:

building a consortium
convening discussions
hosting workshops
engaging communities
collaborative bid writing
desk research
coordination of the consortium
developing mechanisms to gather impact and benefits data which will be required at the Grand Challenge phase

This list is not exhaustive.

Further details on the impacts and benefits data for the Grand Challenge phase will be shared with applicants who are successful in this EoI phase.

The Grand Challenge phase

Consortia awarded funding at the EoI phase will be invited to apply for the Grand Challenge phase competition, which will open in, or after, June 2025. Further details about the application timeline and requirements for this phase will be released in due course.

Grand Challenge phase funding must be used to invest in the capacity and capability of the consortia to deliver across four key goals:

drive disruptive and novel technologies or processes in medicines manufacturing to optimise production efficiency, minimise waste and reduce emissions, aligning with global sustainability goals
facilitate the effective implementation of innovative solutions and promote their adoption across the medicines manufacturing sector, ensuring scalability and widespread utilisation
enhance the UK’s attractiveness as a prime location for investment in medicines manufacturing, thereby stimulating economic growth and enhancing resilience in the sector
strengthen the UK's manufacturing innovation ecosystem through collaborative partnerships between academia, industry, and government entities, promoting knowledge exchange and collaborative initiatives to enhance sustainable manufacturing practices

Who should be involved in a consortium?

Your consortium will be required to demonstrate how they will comprise a supply chain (where appropriate) capable of delivering and exploiting the Grand Challenge objectives.

The organisations in your project, as well as the relationships and their roles in the consortium, can change between the EoI phase and Grand Challenge phases.

Portfolio approach

We want to fund a variety of projects across different technologies, themes, locations, markets and technological maturities. We call this a portfolio approach.

Specific themes

We welcome proposals from collaborations across different sectors.

Your Grand Challenge project must focus on at least one pillar and address both enablers:

Pillar 1. Green chemistry:

biocatalysis, new chemocatalysis
flow chemistry
solvent free systems
sustainable solvents
biomanufacturing for active pharmaceutical ingredient (API), plastics and biopolymers
technology switches away from solid phase synthesis

Pillar 2. Circularity

recycle and reuse of materials, for example, solvents, water, plastics, packaging
identify materials with potential for circularity

Pillar 3. Productivity and resource efficiency

continuous processing
process intensification
digital processing, digitalisation, automation or robotics.
utilise shared data to enable use of artificial intelligence and machine learning
analyse waste in the supply chain
streamline development processes
reduction of energy use
increasing yield, productivity and efficiencies

These are examples of specific themes sitting within each of the pillars however this is not an exhaustive list and proposals do not have to be restricted to these.

Skills and training can be considered alongside any of the three pillars.

Enabler 1. Measurements, data and standards

align with emerging approaches, for example, life cycle analysis (LCA), carbon footprint reporting and demonstrating efficiency in resource efficiency and reduced emissions

Enabler 2. Regulations

identify regulatory challenges and propose solution

These are examples of specific themes sitting within each of the enablers, however this is not an exhaustive list and proposals do not have to be restricted to these.

We encourage proposals that align with national innovation and policy priorities, such as those set out in:

Projects we will not fund

For the EoI, we will not fund:

activity that does not contribute to the development of a proposal for the Grand Challenge phase of the programme
activity that an existing innovation network was already undertaking or so-called ‘business as usual’
laboratory based experimental development
non-human medicines
medical device manufacturing

For the Grand Challenge we will not fund infrastructure and facility design without appropriate demonstration.

This is not an exhaustive list and further details will follow at the Grand Challenge phase.

We cannot fund projects that:

involve primary production in fishery and aquaculture
involve primary production in agriculture
have activities relating to the purchase of road freight transport
are not allowed under De minimis regulation restrictions
are not eligible to receive Minimal Financial Assistance
are dependent on export performance, for example, giving an award to a baker on the condition that they export a certain quantity of bread to another country
are dependent on domestic inputs usage, for example, if we give an award to a baker on the condition that they use 50% UK flour in their product

14 August 2024: Competition opens
15 August 2024: Online briefing event at 10.30am: watch the recording
Briefing slides are now available to download from supporting information.
16 October 2024 11:00am: Competition closes
4 November 2024: Applicants notified
6 November 2024: Successful applicant briefing – all successful applicants must attend: link to follow

Before you start

You must read the guidance on applying for a competition on the Innovation Funding Service before you start.

Before submitting, it is the lead applicant’s responsibility to make sure:

that all the information provided in the application is correct
your proposal meets the eligibility and scope criteria
all sections of the application are marked as complete
if collaborative, that all partners have completed all assigned sections and accepted the terms and conditions (T&Cs)

You can reopen your application once submitted, up until the competition deadline. You must resubmit the application before the competition deadline.

What we ask you

The application is split into three sections:

Project details.
Application questions.
Finances.

Accessibility and Inclusion

You can contact us at any time to ask for guidance.

You can contact Innovate UK by email or call 0300 321 4357. Our phone lines are open from 9am to 12pm and 2pm to 5pm UK time, Monday to Friday (excluding bank holidays).

1. Project details

This section provides background for your application and is not scored.

Application team

Decide which organisations will work with you on the project and invite people from those organisations to help complete the application.

Application details

Give your project’s title, start date and duration.

Project summary

Describe your project briefly and be clear about what makes it innovative. We use this section to assign experts to assess your application.

Your answer can be up to 400 words long.

Public description

Describe your project in detail, and in a way that you are happy to see published. Do not include any commercially sensitive information. If we award your project funding, we will publish this description. This can happen before you start your project.

Your answer can be up to 400 words long.

Scope

Describe how your project fits the scope of the competition. If your project is not in scope, it will not be sent for assessment. We will tell you the reason why.

Your answer can be up to 400 words long.

2. Application questions

The assessors will score all your answers apart from questions 1 to 5. You will receive feedback for each scored question. Find out more about how our assessors assess and how we select applications for funding.

You must answer all questions. Do not include any website addresses (URLs) in your answers.

Question 1. Applicant location (not scored)

You must state the name and full registered address of your organisation and any partners working on your project.

We are collecting this information to understand the geographical location of all applicants.

Your answer can be up to 400 words long.

Question 2. Minimal Financial Assistance declaration (not scored)

If you are a business you must download the declaration template. You must complete this, declaring any funding received under Minimal Financial Assistance (previously referred to as Special Drawing Rights) or De minimis awards, (from any source of public funding) in the applicable period.

You must complete all the fields on your form before uploading.

You must write ‘declaration attached’ in the question text box.

You must upload the completed declaration as an appendix. It must be a PDF no larger than 10MB and must be in 11 point font size.

You must keep all documentation relating to Minimal Financial Assistance (previously referred to as Special Drawing Rights) and other De minimis awards for a period of six years and be prepared to release it to any public funding body which requests it.

You do not need to download or complete the declaration template if you are not a business. If there is not a business in your consortium you must write ‘declaration not required’ and upload a blank document.

Question 3. Animal testing (not scored)

Will your project involve any trials with animals or animal testing?

You must select one option:

We will only support innovation projects conducted to the highest standards of animal welfare.

Further information for proposals involving animal testing is available at the UKRI Good Research Hub and NC3R’s animal welfare guidance.

Question 4. Permits and licences (not scored)

Will you have the correct permits and licences in place to carry out your project?

We are unable to fund projects who do not have the correct permits or licences in place by your project start date.

You must select one option:

Yes
No
In process of being applied for
Not applicable

Question 5. Pillar alignment (not scored)

Which pillars does your project align with, or intend to align with:

circularity
green chemistry
productivity and resource

Your answer can be up to 150 words long.

Question 6: Consortium building

How do you plan to leverage this seed funding to build a consortium capable of preparing a comprehensive case for Phase 2: Grand Challenge?

Describe:

what activities you intend to carry out during this EoI phase to develop the consortium
any planned research and information-gathering initiatives that will inform the Grand Challenge design, including feasibility studies, market analysis, and environmental impact assessments
how these activities will lay the groundwork for a robust and well-coordinated consortium to develop a strong, competitive proposal for the Grand Challenge award
the preliminary strategies and activities your network will undertake during the EoI phase to tackle sustainability challenges within the medicines manufacturing sector

Your answer can be up to 1000 words long.

Question 7. Team and resources

Who is in the project team and what are their roles?

Explain:

the roles, skills and experience of all members of the project team for this expression of interest
how each potential consortium partner will contribute to the development of the Grand Challenge
the current relationships between partners and how you expect these to develop during this EoI phase
any additional roles or organisations you believe will be needed to bring into the consortium to suitably address sustainability challenges within the medicines manufacturing sector
the anticipated benefits of a diverse and multidisciplinary team
existing partnerships, initiatives or networks you plan to leverage in the development of your consortium
how you propose to engage partners from across the medicines manufacturing supply chain to build your consortium, or explain why your project does not require partners from across the supply chain if you believe this is the case

Your answer can be up to 1000 words long.

Question 8. Proposed innovation focus

What will be the proposed innovation focus of your Grand Challenge, with reference to the three pillars and two enablers:

circularity
green chemistry
productivity and resource
regulations
measurements, standards and data

Describe:

the sustainability barriers and challenges faced in the area in which your proposed consortium will operate
the expected challenges related to regulations, measurements, standards and data which you foresee potentially impacting the exploitation, commercialisation or adoption of your innovation
how you propose to address the challenges related to regulations, measurements, standards and data
the significance of advancing sustainable medicines manufacturing for your consortium
initial Grand Challenge ideas for how your consortium will use the EoI phase to address those sector-specific challenges and unlock innovation
the broader impact of implementing the output of your Grand Challenge, including sustainable practices in medicines manufacturing and environmental, economic and social benefits
any work you have already done to harness the power of sustainable medicines manufacturing innovation in your sector
any previous work or funding received to support this or other skills that are relevant

If you are applying for funding to scale up and expand your existing consortium, you must explain how your planned activities within this EoI phase represent an expansion, scaling or change in focus from business as usual.

Your answer can be up to 1000 words long.

Question 9. Costs and value for money

How much will the EoI phase cost and how does it represent value for money for the team and the taxpayer?

In terms of the project goals, explain:

the total eligible project costs
the grant you are requesting
how this project represents value for money for you and the taxpayer
the balance of costs and grant across the project partners if applicable

Your answer can be up to 400 words long.

3. Finances

Each organisation in your project must complete their own project costs, organisation details and funding details in the application for this expression of interest (EoI) competition.

Academic institutions must complete and upload a Je-S form.

Your project’s total costs and grant funding request must match and must not exceed the maximum of £100,000. If your total costs or grant funding request exceed this maximum, then your application will be made ineligible.

You can make reference to any additional voluntary contribution in your application question answers but these must not be detailed in this finance section.

For full details on what costs you can claim see our project costs guidance. You can also view our application finances video.

Assessment

Your application will be reviewed by five independent assessors based on the content of your application and their skills or expertise relevant to your project. All of the scores awarded will count towards the total score used to make the funding decision unless you are notified otherwise.

You can find out more about our assessment process in the General Guidance.

Your submitted application will be assessed against these criteria:

Sustainable Medicines Manufacturing EoI - assessor guidance for applicants.pdf (opens in a new window)

Background and further information

The need for sustainable innovation in the medicines manufacturing sector is paramount due to escalating environmental, economic and social pressures. Traditional medicines manufacturing processes are resource-intensive, generating significant waste and emissions that contribute to pollution and climate change. Healthcare providers led by the NHS are challenging the sector to provide medicines with a lower carbon footprint.

Innovative approaches to sustainable medicines manufacturing can address these challenges by reducing resource consumption, minimising waste and lowering greenhouse gas emissions. Implementing green chemistry principles and adopting circular economy practices can lead to more efficient and environmentally friendly production processes. These innovations not only reduce the sector’s ecological impact but also enhance cost-effectiveness and competitiveness by optimising resource use and lowering production costs.

Advancing sustainable medicines manufacturing innovation is essential to ensuring the long-term viability of the sector. It supports the global transition to a low-carbon economy, promotes economic resilience and safeguards environmental and public health, making it a critical priority for industry stakeholders.

The Sustainable Medicines Manufacturing Innovation Programme is funded as part of the wider VPAG Investment Programme agreed as part of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).

The VPAG Investment Programme is a new joint government-industry programme to strengthen the UK’s global competitiveness in health and life sciences and drive innovation-led growth. Enabled by circa £400 million of funding from scheme members, it will target investment across the four nations, with initiatives in three focus areas; clinical trials, health technology assessment and manufacturing.

Briefing slides

Briefing slides are available to download here.

Applicant briefing Sustainable Medicines Manufacturing – Eoi v2.pdf (opens in a new window)

If your application is successful

If you are successful with this application, you will be asked to set up your project.

You will be notified by email on the date published for this competition. Notifications may be sent any time up to 5pm.

At least one member of your consortium must attend a one hour briefing webinar on 6 November 2024.

You must follow the unique link embedded in your email notification. This takes you to your Innovation Funding Service (IFS) Set Up portal, where we gather the information to set up your project.

Watch our video on what steps there are before a project starts.

During the project set up you will be assigned a delivery executive who will guide you through the whole project set up process.

Following your email notification, you will need to provide the following within 5 days (including weekends and bank holidays):

the name and contact details of your project manager and project finance lead
a finance contact for all partners
a copy of your bank details

You will need to provide the following within 30 days (including weekends and bank holidays):

a collaboration agreement, if collaborative
an exploitation plan

You will have 90 days (including weekends and bank holidays) to complete all of your project set up. Within this time, you will also be required to submit:

project location
any answers to financial queries we have requested
any requested documentation to support your project such as a spend profile

Your funding offer may be withdrawn if project setup is not completed within this or an alternative timeframe as advised by Innovate UK.

In order for us to process your claims, you must make sure you have a valid UK business bank account. It can take several weeks for a new account to be created if required. We recommend starting this process as early as possible to avoid any delays to your project start date.

The bank account which grant is to be paid into must:

be a business account in the same name as the organisation listed in IFS
be from a UK bank regulated by the Prudential Regulation Authority (PRA)
have a cheque and credit clearing facility

Online accounts are eligible as long as they meet the above criteria.

Innovate UK will accept most banking societies apart from:

Viva Wallet
Intesa Sanpaolo
Equals Money UK Limited
Modulr FS Limited

If you have any doubts that your bank account will not meet Innovate UK's funding criteria, you can use the sort code checker. If you input the sort code and find a tick next to the ‘BACS Direct Credit payments can be sent to this sort code’, this will give you an indication that the bank account you hold is acceptable.

Finance checks

We will carry out checks to make sure you are an established company with access to the funds necessary to complete the project.

You must check your IFS portal regularly and respond to any requests we have sent for additional information to avoid any delays.

Failure to complete project setup may result in your grant offer being withdrawn.

Your Grant offer letter (GOL)

Once you have successfully completed project setup, we will issue your GOL.

The GOL will be made available on your IFS portal. You will need to sign and upload this for us to approve. Once approved we will send you an email with permission to start your project on your confirmed start date.

You must not start your project before the date stated on your email and GOL. Any costs incurred before your agreed start date cannot be claimed as part of your grant.

If your GOL is approved on or before the fifteenth of the month it will be dated from the first of that month. If your GOL is approved after the fifteenth, it will be dated the first of the next month.

If your application is unsuccessful

If you are unsuccessful with your application this time, you can view feedback from the assessors. This will be available to you on your IFS portal following notification.

Sometimes your application will have scored well, and you will receive positive comments from the assessors. You may be unsuccessful as your average score was not above the funding threshold or your project has not been selected under the portfolio approach if this is applied for this competition.

Find a project partner

If you want help to find a project partner, contact Innovate UK Business Connect.

Protecting your innovation

A Secure Innovation campaign has been developed to help founders and leaders of innovative startups protect their technology, competitive advantage, and reputation.

This was developed by UK’s National Protective Security Authority (NPSA) and the National Cyber Security Centre (NCSC).

Data sharing

This competition is jointly operated by Innovate UK and the Department of Health and Social Care (DHSC) (each an ‘agency’).

Any relevant information submitted and produced during the application process concerning your application can be shared by one agency with the other, for its individual storage, processing and use.

This means that any information given to or generated by Innovate UK in respect of your application may be passed on to DHSC and vice versa. This would include, but is not restricted to:

the information stated on the application, including the personal details of all applicants
scoring and feedback on the application
information received during the management and administration of the grant, such as Monitoring Service Provider reports and Independent Accountant Reports

Innovate UK and DHSC are directly accountable to you for their holding and processing of your information, including any personal data and confidential information. Data is held in accordance with their own policies. Accordingly, Innovate UK, Innovate UK Business Connect and DHSC will be data controllers for personal data submitted during the application.

Innovate UK’s Privacy Policy

Innovate UK Business Connect Privacy Policy

Department of Health and Social Care Privacy Policy

Innovate UK complies with the requirements of UK GDPR and the Data Protection Act 2018, and is committed to upholding data protection legislation, and protecting your information in accordance with data protection principles.

The Information Commissioner’s Office also has a useful guide for organisations, which outlines the data protection principles.

Contact us

If you need more information about how to apply or you want to submit your application in Welsh, email support@iuk.ukri.org or call 0300 321 4357.

Our phone lines are open from 9am to 12pm and 2pm to 5pm UK time, Monday to Friday (excluding bank holidays).

Innovate UK or any of our partners will not tolerate abusive language in any written or verbal correspondence, applications, social media or any other form that might affect staff.

Need help with this service? Contact us